Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC

Blood

Volumn 117, Issue 26, 2011, Pages 7032-7041

  Barao, Isabel ^a   Alvarez, Maite ^b   Ames, Erik ^b   Orr, Mark T ^c   Stefanski, Heather E ^d   Blazar, Bruce R ^d   Lanier, Lewis L ^c   Anderson, Stephen K ^e   Redelman, Doug ^a   Murphy, William J ^b  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; CYTOLYSIS; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE RECONSTITUTION; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOSTIMULATION; LISTERIA MONOCYTOGENES; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

EID: 79959832208     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-316653     Document Type: Article

References (33)

1. Miller JS. Biology of natural killer cells in cancer and infection. Cancer Invest. 2002;20(3):405-419. (Pubitemid 34496573)
2. Barao I, Murphy WJ. The immunobiology of natural killer cells and bone marrow allograft rejection. Biol Blood Marrow Transplant. 2003;9(12):727-741. (Pubitemid 38145742)
3. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol. 2001;19:291-330. (Pubitemid 32368038)
4. Lanier LL. NK cell receptors. Annu Rev Immunol. 1998;16:359-393. (Pubitemid 28183369)
5. Yokoyama WM, Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev. 2006;214:143-154. (Pubitemid 44707908)
6. Joncker NT, Raulet DH. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol Rev. 2008;224:85-97.
7. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005;436(7051):709-713. (Pubitemid 41117274)
8. Orr MT, Murphy WJ, Lanier LL. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol. 2010;11(4):321-327.
9. Salcedo M, Diehl AD, Olsson-Alheim MY, et al. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J Immunol. 1997;158(7):3174-3180. (Pubitemid 127484031)
10. Korten S, Wilk E, Gessner JE, Meyer D, Schmidt RE. Altered donor and recipient Ly49+ NK-cell subsets in allogeneic H-2d → H-2b and H-2b → H-2d bone marrow chimeras. J Immunol. 1999;163(11):5896-5905.
11. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005;5(3):201-214. (Pubitemid 40364822)
12. Yu J, Venstrom JM, Liu XR, et al. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation. Blood. 2009;113(16):3875-3884.
13. Fuchs EJ, Huang XJ, Miller JS. HLA-haploidentical stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2010;16(1 suppl):S57-S63.
14. Raziuddin A, Longo DL, Bennett M, Winkler-Pickett R, Ortaldo JR, Murphy WJ. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. Blood. 2002;100(8):3026-3033.
15. Koh CY, Blazar BR, George T, et al. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood. 2001;97(10):3132-3137.
16. Kollmann TR, Reikie B, Blimkie D, et al. Induction of protective immunity to Listeria monocytogenes in neonates. J Immunol. 2007;178(6):3695-3701. (Pubitemid 46417637)
17. Saleh A, Makrigiannis AP, Hodge DL, Anderson SK. Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus. J Immunol. 2002;168(10):5163-5169. (Pubitemid 34495982)
18. Fahlén L, Lendahl U, Sentman CL. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells. J Immunol. 2001;166(11):6585-6592. (Pubitemid 32467198)
19. Hanke T, Takizawa H, McMahon CW, et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity. 1999;11(1):67-77. (Pubitemid 29359958)
20. Ortaldo JR, Mason AT, Winkler-Pickett R, Raziuddin A, Murphy WJ, Mason LH. Ly-49 receptor expression and functional analysis in multiple mouse strains. J Leukoc Biol. 1999;66(3):512-520. (Pubitemid 29439260)
21. Mason LH, Willette-Brown J, Mason AT, McVicar D, Ortaldo JR. Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion. J Immunol. 2000;164(2):603-611. (Pubitemid 30043679)
22. Becknell B, Caligiuri MA. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol. 2005;86:209-239. (Pubitemid 40215694)
23. Saleh A, Davies GE, Pascal V, et al. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity. 2004;21(1):55-66. (Pubitemid 38925267)
24. Roth C, Carlyle JR, Takizawa H, Raulet DH. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity. 2000;13(1):143-153.
25. Proteau MF, Rousselle E, Makrigiannis AP. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics. 2004;84(4):669-677. (Pubitemid 39310944)
26. Raziuddin A, Longo DL, Mason L, Ortaldo JR, Murphy WJ. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice. Int Immunol. 1996;8(12):1833-1839. (Pubitemid 27007733)
27. Sentman CL, Streilein R, Kumar V, Bennett M. Kinetics and location of bone marrow cell graft rejection by irradiated mice. Nat Immun Cell Growth Regul. 1988;7(2):95-105.
28. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009;457(7229):557-561.
29. Xie X, Stadnisky MD, Brown MG. MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. J Immunol. 2009;182(11):7163-7171.
30. Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood. 2003;101(9):3730-3740. (Pubitemid 36857966)
31. Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 2001;98(3):705-713.
32. Fischer JC, Ottinger H, Ferencik S, et al. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J Immunol. 2007;178(6):3918-3923. (Pubitemid 46417662)
33. Williams NS, Kubota A, Bennett M, Kumar V, Takei F. Clonal analysis of NK-cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression. Eur J Immunol. 2000;30(7):2074-2082. (Pubitemid 30456204)